BeiGene, Ltd. (ONC) Ownership
ONC ownership summary
as of October 17, 2026- Institutions
- 33.3% of shares outstanding
- Insiders
- 17.28% of shares outstanding
- Shares outstanding
- 104.9M
- Float
- 81.0M shares available to trade
- Short interest
- 2.39% 1.9M shares short
- Days to cover
- 4.96 short interest up 13.2% vs prior month
- Institutions 33.30%
- Insiders 17.28%
- Other investors 49.42%
ONC top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Baker Bros Advisors LP | 7.74% | 8.8M | $3.25B | +2,514 (+0.0%) | June 30, 2026 |
| 2 | PRIMECAP Management Company | 4.40% | 5.0M | $1.85B | +32,750 (+0.7%) | June 30, 2026 |
| 3 | Capital Research & Mgmt Co - Division 3 | 3.70% | 4.2M | $1.55B | +51,495 (+1.2%) | June 30, 2026 |
| 4 | FMR Inc | 2.18% | 2.5M | $914.7M | −1.2M (−32.9%) | June 30, 2026 |
| 5 | Capital World Investors | 1.98% | 2.2M | $830.2M | +626,895 (+38.6%) | June 30, 2026 |
| 6 | Citadel Advisors Llc | 1.25% | 1.4M | $526.1M | +393,219 (+38.1%) | June 30, 2026 |
| 7 | Temasek Holdings Ltd. | 0.74% | 846K | $312.1M | −16,914 (−2.0%) | June 30, 2026 |
| 8 | T. Rowe Price Associates, Inc. | 0.67% | 759K | $280.0M | +218,983 (+40.6%) | June 30, 2026 |
| 9 | BlackRock Inc | 0.61% | 695K | $256.4M | +37,117 (+5.6%) | June 30, 2026 |
| 10 | Millennium Management LLC | 0.48% | 543K | $200.5M | +338,477 (+165.2%) | June 30, 2026 |
| 11 | Morgan Stanley - Brokerage Accounts | 0.44% | 497K | $183.6M | +32,965 (+7.1%) | June 30, 2026 |
| 12 | Siren, L.L.C. | 0.41% | 465K | $171.6M | — | June 30, 2026 |
| 13 | Bank of America Corp | 0.39% | 439K | $162.1M | +34,063 (+8.4%) | June 30, 2026 |
| 14 | Baird Financial Group, Inc. | 0.32% | 369K | $136.2M | +19,327 (+5.5%) | June 30, 2026 |
| 15 | Man Group PLC | 0.27% | 307K | $113.5M | +65,541 (+27.1%) | June 30, 2026 |
| 16 | Capital International Inc /ca/ | 0.27% | 305K | $112.7M | +3,234 (+1.1%) | June 30, 2026 |
| 17 | Candriam Luxembourg S.C.A. | 0.25% | 290K | $106.9M | +30,004 (+11.6%) | June 30, 2026 |
| 18 | Two Sigma Investments LLC | 0.25% | 287K | $105.8M | +253,009 (+754.3%) | June 30, 2026 |
| 19 | UBS Group AG | 0.23% | 259K | $95.4M | −156,741 (−37.7%) | June 30, 2026 |
| 20 | Arrowstreet Capital Limited Partnership | 0.22% | 250K | $92.2M | +139,172 (+125.8%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 16 holders added 2.3M shares and 3 cut 1.4M.
ONC top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | American Funds New Perspective A | 2.34% | 2.7M | $983.2M | — | June 30, 2026 |
| 2 | Vanguard PRIMECAP Inv | 2.06% | 2.3M | $866.4M | +28,000 (+1.2%) | June 30, 2026 |
| 3 | Vanguard Capital Opportunity Inv | 1.04% | 1.2M | $436.3M | +12,500 (+1.1%) | June 30, 2026 |
| 4 | American Funds EUPAC A | 0.62% | 701K | $258.6M | −29,565 (−4.0%) | June 30, 2026 |
| 5 | American Funds New World A | 0.60% | 677K | $250.0M | +14,738 (+2.2%) | June 30, 2026 |
| 6 | PRIMECAP Odyssey Aggressive Growth | 0.58% | 660K | $243.5M | −1,070 (−0.2%) | June 30, 2026 |
| 7 | iShares Biotechnology ETF | 0.58% | 656K | $242.2M | −4,976 (−0.8%) | September 30, 2026 |
| 8 | Fidelity Growth Company Fund | 0.55% | 624K | $230.3M | — | August 31, 2026 |
| 9 | PRIMECAP Odyssey Growth | 0.52% | 586K | $216.4M | −9,100 (−1.5%) | June 30, 2026 |
| 10 | American Funds New Economy A | 0.43% | 492K | $181.5M | +491,760 (0.0%) | June 30, 2026 |
| 11 | American Fds Global Insight F-3 | 0.33% | 374K | $138.0M | — | June 30, 2026 |
| 12 | Capital Group NewPers LUX Z | 0.28% | 319K | $117.7M | −14,477 (−4.3%) | June 30, 2026 |
| 13 | First Trust NYSE Arca Biotech ETF | 0.27% | 303K | $111.9M | — | September 30, 2026 |
| 14 | T. Rowe Price International Stock | 0.23% | 260K | $95.9M | −1,531 (−0.6%) | August 31, 2026 |
| 15 | Capital Group GNewPers LUX P | 0.21% | 235K | $86.7M | +5,423 (+2.4%) | June 30, 2026 |
| 16 | KBC Eq Fd Em Markets Resp Inv Corp C | 0.16% | 181K | $66.8M | +106,134 (+141.7%) | December 31, 2025 |
| 17 | Baird Chautauqua International Gr Instl | 0.16% | 179K | $66.1M | −28,135 (−13.6%) | June 30, 2026 |
| 18 | Fidelity Growth Company K6 | 0.15% | 176K | $64.8M | — | August 31, 2026 |
| 19 | Capital Group Global Growth Equity ETF | 0.15% | 175K | $64.5M | +414 (+0.2%) | September 30, 2026 |
| 20 | BOCHK China Equity A HKD | 0.15% | 173K | $63.9M | — | March 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
ONC insider transactions
latest 20| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-08 | Chan Henry Lee | Sell | $311.59 | 332 | $103,448 |
| 2026-03-11 | Chan Henry Lee | Sell | $300.00 | 341 | $102,300 |
| 2026-02-04 | Chan Henry Lee | Sell | $349.52 | 1,660 | $580,203 |
| 2026-01-07 | Chan Henry Lee | Sell | $331.76 | 664 | $220,289 |
| 2025-12-16 | John Oyler | Sell | $302.87 | 24,369 | $7.4M |
| 2025-12-15 | John Oyler | Sell | $307.79 | 75,631 | $23.3M |
| 2025-12-11 | Chan Henry Lee | Sell | $325.00 | 332 | $107,900 |
| 2025-11-26 | Corazon (Corsee) D Sanders | Sell | $340.90 | 2,627 | $895,544 |
| 2025-11-17 | Xiaobin Wu | Sell | $380.43 | 3,991 | $1.5M |
| 2025-11-17 | Xiaobin Wu | Sell | $380.43 | 3,991 | $1.5M |
| 2025-11-13 | Xiaobin Wu | Sell | $380.54 | 6,009 | $2.3M |
| 2025-11-12 | Chan Henry Lee | Sell | $349.17 | 996 | $347,773 |
| 2025-11-12 | Xiaobin Wu | Sell | $356.02 | 10,000 | $3.6M |
| 2025-10-08 | Chan Henry Lee | Sell | $350.40 | 10,671 | $3.7M |
| 2025-09-16 | John Oyler | Sell | $325.71 | 27,803 | $9.1M |
| 2025-09-10 | Chan Henry Lee | Sell | $325.53 | 10,006 | $3.3M |
| 2025-09-09 | Lai Wang | Sell | $350.06 | 5,000 | $1.8M |
| 2025-09-05 | Corazon (Corsee) D Sanders | Sell | $337.00 | 2,665 | $898,105 |
| 2025-09-02 | Titus B Ball | Sell | $326.76 | 122 | $39,865 |
| 2025-08-14 | Xiaobin Wu | Sell | $305.06 | 39,936 | $12.2M |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
ONC shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns ONC
Institutional investors own 33.3% of BeiGene's shares and insiders 17.28%. The largest holder is Baker Bros Advisors LP with 7.74% of the shares (8.8M), as of June 30, 2026. Among the top 20 institutions, 16 added shares and 3 reduced their stake in the latest filings. Short interest is 2.39% of the float, or 4.96 days of average trading volume. The share count rose 111.1% since 2014.
Related: ONC analyst forecast, ONC key metrics. See the ONC stock overview for the latest quote and news.
ONC ownership FAQ
Who owns the most BeiGene stock?
The largest shareholders of BeiGene are Baker Bros Advisors LP (7.74%), PRIMECAP Management Company (4.40%), Capital Research & Mgmt Co - Division 3 (3.70%), FMR Inc (2.18%), Capital World Investors (1.98%).
What percentage of BeiGene is owned by institutions?
Institutions hold 33.3% of BeiGene's shares outstanding; insiders hold 17.28%.
Which funds own BeiGene?
The largest fund holders of BeiGene are American Funds New Perspective A (2.34%), Vanguard PRIMECAP Inv (2.06%), Vanguard Capital Opportunity Inv (1.04%), American Funds EUPAC A (0.62%), American Funds New World A (0.60%).
What is BeiGene's short interest?
1.9M shares of BeiGene were sold short, 2.39% of the float; at the average daily volume it would take 4.96 days to cover.
Are insiders buying or selling BeiGene?
Of the latest 20 reported insider transactions in BeiGene (since August 14, 2025), 0 were purchases and 20 were sales.
How many shares of BeiGene are outstanding?
BeiGene has 104.9M shares outstanding, of which 81.0M are in the public float.